Molecular targets for therapy of hepatitis B virus-induced hepatocellular carcinoma.

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Molecular targets for therapy of hepatitis B virus-induced hepatocellular carcinoma.

Minerva gastroenterologica e dietologica - 1 Dec 2006

Tharayil V S, Roberts L R

Abstract excerpt

Chronic hepatitis B virus (HBV) infection is the most frequent risk factor for development of hepatocellular carcinoma (HCC) worldwide. Studies of the molecular genetics and pathophysiology of HCC suggest that there are significant differences in the allelic imbalance, genome copy number, and gen...

Topics

Aflatoxins
Alleles
Apoptosis
Carcinoma, Hepatocellular
Cell Cycle
DNA, Viral
Gene Expression
Genes, Viral
Genetic Therapy
Genomic Instability
Genotype
Hepatitis B virus
Hepatitis B, Chronic
Humans
Liver Neoplasms
Phenotype
Risk Factors
Virus Integration

Source

Open in PubMed

Identifiers

PMID: 17108869

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-17108869-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics